| The therapeutic potential of interleukin-10 in neuroimmune diseases AJ Kwilasz, PM Grace, P Serbedzija, SF Maier, LR Watkins Neuropharmacology 96, 55-69, 2015 | 235 | 2015 |
| Prior voluntary wheel running attenuates neuropathic pain PM Grace, TJ Fabisiak, SM Green-Fulgham, ND Anderson, KA Strand, ... Pain 157 (9), 2012, 2016 | 127 | 2016 |
| Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats AJ Kwilasz, SS Negus Journal of Pharmacology and Experimental Therapeutics 343 (2), 389-400, 2012 | 75 | 2012 |
| Effects of the fatty acid amide hydrolase (FAAH) inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats AJ Kwilasz, RA Abdullah, JL Poklis, AH Lichtman, SS Negus Behavioural pharmacology 25 (2), 119, 2014 | 45 | 2014 |
| Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists AJ Kwilasz, A Ellis, J Wieseler, L Loram, J Favret, A McFadden, ... Brain, Behavior, and Immunity 69, 470-479, 2018 | 30 | 2018 |
| Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats SM Green-Fulgham, JB Ball, AJ Kwilasz, T Fabisiak, SF Maier, ... Pain 160 (11), 2634, 2019 | 23 | 2019 |
| Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone AJ Kwilasz, LS Todd, JC Duran-Malle, AEW Schrama, EH Mitten, ... Behavioural brain research 396, 112896, 2021 | 21 | 2021 |
| Stereochemistry and innate immune recognition:(+)‐norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll‐like receptor 4 signaling X Zhang, Y Peng, PM Grace, MD Metcalf, AJ Kwilasz, Y Wang, T Zhang, ... The FASEB Journal 33 (8), 9577-9587, 2019 | 17 | 2019 |
| A single peri-sciatic nerve administration of the adenosine 2A receptor agonist ATL313 produces long-lasting anti-allodynia and anti-inflammatory effects in male rats AJ Kwilasz, SMG Fulgham, A Ellis, HP Patel, JC Duran-Malle, J Favret, ... Brain, Behavior, and Immunity 76, 116-125, 2019 | 16 | 2019 |
| Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain AJ Kwilasz, SMG Fulgham, JC Duran-Malle, AEW Schrama, EH Mitten, ... Brain, Behavior, and Immunity 93, 80-95, 2021 | 14 | 2021 |
| Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hunger DC Jewett, A Klockars, TR Smith, C Brunton, MA Head, RL Tham, ... Behavioural Brain Research 380, 112369, 2020 | 7 | 2020 |
| Involvement of TLR2–TLR4, NLRP3, and IL-17 in pain induced by a novel Sprague-Dawley rat model of experimental autoimmune encephalomyelitis AJ Kwilasz, MA Clements, TA Larson, KM Harris, ST Litwiler, BJ Woodall, ... Frontiers in Pain Research, 146, 2022 | 5 | 2022 |
| T cell transgressions: Tales of T cell form and function in diverse disease states KM Harris, MA Clements, AJ Kwilasz, LR Watkins International Reviews of Immunology, 1-42, 2021 | 4 | 2021 |
| Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice AJ Kwilasz, LS Harris, RE Vann Pharmacology Biochemistry and Behavior 94 (1), 114-118, 2009 | 4 | 2009 |
| Preconditioning by voluntary wheel running attenuates later neuropathic pain via nuclear factor E2–related factor 2 antioxidant signaling in rats SM Green-Fulgham, ME Harland, JB Ball, J Li, MJ Lacagnina, H D'Angelo, ... PAIN 163 (10), 1939-1951, 2022 | 3 | 2022 |
| Varenicline does not alter brain stimulation reward thresholds and reverses nicotine‐facilitated thresholds in rats RE Vann, KM Tobey, SL Lobe, B Kipps, AJ Kwilasz, MD Aceto, LS Harris Drug Development Research 72 (4), 310-314, 2011 | 3 | 2011 |
| Interleukin-1beta and inflammasome expression in spinal cord following chronic constriction injury in male and female rats SM Green-Fulgham, JB Ball, AJ Kwilasz, ME Harland, MG Frank, ... Brain, Behavior, and Immunity 115, 157-168, 2024 | 1 | 2024 |
| Safety of XT-150 Human IL-10v Plasmid Gene Therapy Intrathecal in a Mouse Neuropathic Pain Model R Chavez, PM Grace, AJ Kwilasz, SM Fulgham, ND Anderson, ... MOLECULAR THERAPY 25 (5), 200-200, 2017 | 1 | 2017 |
| Effects of the cannabinoid 2 receptor‐selective agonist GW405833 in assays of acute pain‐stimulated and paindepressed behavior in rats A Kwilasz, S Negus The FASEB Journal 27, 886.9-886.9, 2013 | 1 | 2013 |
| Intrathecal non-viral interleukin-10 gene therapy ameliorates neuropathic pain as measured by both classical static allodynia and a novel supra-spinally mediated pain assay … MA Clements, AJ Kwilasz, ST Litwiler, Z Sents, BJ Woodall, K Hayashida, ... Brain, Behavior, and Immunity, 2023 | | 2023 |
